- Home
- AXGN vs LENZ Comparison
AXGN vs LENZ Comparison
Compare AXGN & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- LENZ
- Stock Information
- Founded
- AXGN N/A
- LENZ 2019
- Country
- AXGN United States
- LENZ United States
- Employees
- AXGN N/A
- LENZ N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- AXGN Health Care
- LENZ Health Care
- Exchange
- AXGN Nasdaq
- LENZ Nasdaq
- Market Cap
- AXGN 797.9M
- LENZ 679.4M
- IPO Year
- AXGN N/A
- LENZ 2021
- Fundamental
- Price
- AXGN $18.00
- LENZ $23.49
- Analyst Decision
- AXGN Strong Buy
- LENZ Strong Buy
- Analyst Count
- AXGN 3
- LENZ 6
- Target Price
- AXGN $18.33
- LENZ $35.40
- AVG Volume (30 Days)
- AXGN 329.1K
- LENZ 100.2K
- Earning Date
- AXGN 02-25-2025
- LENZ 11-06-2024
- Dividend Yield
- AXGN N/A
- LENZ 61.39%
- EPS Growth
- AXGN N/A
- LENZ N/A
- EPS
- AXGN N/A
- LENZ N/A
- Revenue
- AXGN $180,855,000.00
- LENZ N/A
- Revenue This Year
- AXGN $19.41
- LENZ N/A
- Revenue Next Year
- AXGN $13.08
- LENZ N/A
- P/E Ratio
- AXGN N/A
- LENZ N/A
- Revenue Growth
- AXGN 18.79
- LENZ N/A
- 52 Week Low
- AXGN $5.55
- LENZ $2.57
- 52 Week High
- AXGN $19.19
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- AXGN 51.69
- LENZ 35.48
- Support Level
- AXGN $17.73
- LENZ $24.01
- Resistance Level
- AXGN $18.80
- LENZ $25.90
- Average True Range (ATR)
- AXGN 0.77
- LENZ 1.08
- MACD
- AXGN -0.08
- LENZ 0.02
- Stochastic Oscillator
- AXGN 52.96
- LENZ 9.02
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.